Future Price to Earnings: organogenesis.com (ORGO)

Graphic logo of Organogenesis Corp (ORGO)

Organogenesis Holdings (ORGO) maintains a flawless courier network that guarantees the prompt delivery of biomaterials. On GURU.Markets, the company's forward P/E for the coming year reflects market expectations, where the 0.00 parameter determines the metric's value. Growth is driven by an aging population and the success of the NuShield and Affinity product lines, although the sector's high R&D intensity creates fierce competition with medical behemoths.

Organogenesis - ORGO Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/17/2026)

Financial and market metric breakdowns for Organogenesis Holdings (ORGO)

- company stock exchange capitalization indicators:
Initial company analysis:Organogenesis Holdings Inc.
Signature product of Organogenesis Corp

Investments in bioengineers and clinical staff at Organogenesis Holdings (ORGO) are laying the foundation for future profit growth. This investment trend is reflected in the company's forward P/E chart through expected returns. This ratio correlates the current share price with the projected earnings per share. Analyzing this relationship allows for the identification of whether the asset is overbought or if its potential is undervalued. The stability of the scientific core confirms the fundamental resilience of the business.

Analysis of competing companies

Future Price to Earnings HCA Holdings (HCA)|Tenet Healthcare - Price to Future Earnings Ratio|Fresenius Medical Care Corp - Projected Price to Earnings|SOLV: Price to Future Earnings Ratio|Encompass - Forward P/E Multiple|UHS - Forward P/E Multiple|DVA: Forward P/E Multiple|RadNet Corp - Future Price to Earnings Multiple|Future Price to Earnings Option Care Health Inc|Forward P/E Multiple surgerypartners.com|Forward P/E Multiple PINC|Market Cap to Projected Earnings National Vision Holdings, Inc.|Forward P/E Multiple PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Projected Price to Earnings Ratio|SEM: Projected Price to Earnings|ASTH - Forward P/E Multiple|MD: Forward P/E Multiple|Price to Expected Earnings Ratio USPH (US Physical Therapy)|Future Price to Earnings The Pennant Group, Inc.|NUTX: Future Price to Earnings Multiple|Forward P/E Multiple AUNA|Projected Price to Earnings SBC Medical Group Holdings Inc SBC|Future Price to Earnings Jeuveau EOLS|Future Price to Earnings Multiple CYH|SKIN: Projected Price to Earnings|Future Price to Earnings Multiple MDWD (MediWound)|BTMD (biote.com) - Projected Price to Earnings|Projected Price to Earnings thejoint.com|DCGO (DocGo, Inc.) - Forward P/E Multiple|Future Price to Earnings PIII|Projected Price to Earnings GANX (Gain Therapeutics Inc.)|Forward P/E Multiple EUDA Health (EUDA)|Basel Medical Group - Projected Price to Earnings|Market Cap to Future Earnings Ratio CLGN (CollPlant Ltd)|cuprina.com.sg - Forward P/E Multiple|Future Price to Earnings Multiple CCM (Concord Medical Services Holdings)|AMS: Forward P/E Multiple|Projected Price to Earnings Ratio MEDIROM Corp (MRM)|ALBT (Avalon GloboCare Corporation) - Forward P/E Multiple|Price to Future Earnings Ratio DHAI (DIH Holding US, Inc.)|Forward P/E Multiple XAGE|Market Cap to Projected Earnings NewGenIvf Group|Future Price to Earnings ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Projected Price to Earnings Ratio|KDLY - Future Price to Earnings|Future Price to Earnings Multiple MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Future Price to Earnings|SSY - Market Cap to Projected Earnings|Future Price to Earnings IMAC Holdings Inc